Johnson & Johnson (JNJ) Short Interest Update

Johnson & Johnson (NYSE:JNJ) was the target of a significant decline in short interest in the month of April. As of April 28th, there was short interest totalling 14,370,293 shares, a decline of 17.4% from the April 13th total of 17,397,650 shares. Based on an average trading volume of 6,259,588 shares, the days-to-cover ratio is presently 2.3 days. Currently, 0.5% of the shares of the company are short sold.

Institutional investors have recently made changes to their positions in the company. Advocacy Wealth Management Services LLC increased its position in Johnson & Johnson by 62.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 801 shares of the company’s stock worth $100,000 after buying an additional 309 shares during the last quarter. Sumitomo Mitsui Financial Group Inc. purchased a new stake in shares of Johnson & Johnson during the first quarter worth $102,000. Lenox Wealth Advisors Inc. increased its stake in shares of Johnson & Johnson by 0.7% in the first quarter. Lenox Wealth Advisors Inc. now owns 871 shares of the company’s stock worth $108,000 after buying an additional 6 shares in the last quarter. Itau Unibanco Holding S.A. purchased a new stake in shares of Johnson & Johnson during the third quarter worth $104,000. Finally, Madden Advisory Services Inc. purchased a new stake in shares of Johnson & Johnson during the first quarter worth $118,000. 65.30% of the stock is currently owned by institutional investors and hedge funds.

Johnson & Johnson (NYSE:JNJ) opened at 127.00 on Friday. The firm has a market capitalization of $342.12 billion, a price-to-earnings ratio of 21.35 and a beta of 0.74. The firm’s 50-day moving average is $124.19 and its 200 day moving average is $119.23. Johnson & Johnson has a one year low of $109.32 and a one year high of $129.00.

Johnson & Johnson (NYSE:JNJ) last announced its earnings results on Tuesday, April 18th. The company reported $1.83 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.77 by $0.06. Johnson & Johnson had a net margin of 22.78% and a return on equity of 25.61%. The business had revenue of $17.77 billion for the quarter, compared to analyst estimates of $18.02 billion. During the same quarter in the previous year, the firm posted $1.68 earnings per share. Johnson & Johnson’s revenue was up 1.6% compared to the same quarter last year. Analysts forecast that Johnson & Johnson will post $7.10 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 13th. Investors of record on Tuesday, May 30th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Thursday, May 25th. This represents a $3.36 dividend on an annualized basis and a yield of 2.65%. This is a positive change from Johnson & Johnson’s previous quarterly dividend of $0.80. Johnson & Johnson’s payout ratio is 54.42%.

Several brokerages have weighed in on JNJ. Vetr upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $132.33 target price on the stock in a research report on Thursday. Morgan Stanley restated an “equal weight” rating and set a $135.00 target price (up from $130.00) on shares of Johnson & Johnson in a research report on Friday. Cowen and Company restated an “outperform” rating and set a $143.00 target price (up from $138.00) on shares of Johnson & Johnson in a research report on Friday. Stifel Nicolaus restated a “hold” rating and set a $128.00 target price (up from $124.00) on shares of Johnson & Johnson in a research report on Thursday. Finally, Jefferies Group LLC restated a “hold” rating and set a $135.00 target price (down from $140.00) on shares of Johnson & Johnson in a research report on Sunday, May 14th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $128.51.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by Markets Daily and is owned by of Markets Daily. If you are accessing this piece of content on another website, it was illegally stolen and reposted in violation of United States & international copyright law. The correct version of this piece of content can be read at https://www.themarketsdaily.com/2017/05/20/johnson-johnson-jnj-short-interest-update.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

12 Month Chart for NYSE:JNJ

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply